Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 08/20/2025 6:04:49 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 5280
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
28155
My one and only sigmoidoscopy was only done with
someconcerns
10/10/2016 12:13:20 PM
28154
I had a friend who had some sort of condition
Drano
10/10/2016 11:58:44 AM
28153
A proctoscopy could be sufficient but what do I
(1)
someconcerns
10/10/2016 11:46:11 AM
28152
Anesthesia in and of itself carries risks. I will
(1)
Drano
10/10/2016 11:43:14 AM
28151
Both procedures (endoscopy and colonoscopy)
scgmck1
10/10/2016 11:34:41 AM
28150
That's the worst case of cranial rectumitis I've
(1)
scgmck1
10/10/2016 11:25:29 AM
28149
Excellent news today on B-UP. Also glad to hear
Loose Lips
10/10/2016 11:08:38 AM
28148
I don't know that it would be a full colonoscopy
Drano
10/10/2016 11:01:44 AM
28147
I would assume that they will be followed till
someconcerns
10/10/2016 10:31:20 AM
28146
One would think they would be outpatients under
(2)
incubus
10/10/2016 10:28:08 AM
28145
SIDE THOUGHT on today's release/news = Have to
(1)
NotRichYet2
10/10/2016 10:19:42 AM
28144
snorted milk out my nose at that line. whould
someconcerns
10/10/2016 10:15:50 AM
28143
Things are difficult when one considers his
incubus
10/10/2016 10:07:59 AM
28142
One has to consider his situation.....
(1)
incubus
10/10/2016 10:03:37 AM
28140
There is a good chance many of the CTIX
someconcerns
10/10/2016 9:42:34 AM
28139
The next cohort with a higher dosage will - IMHO-
(2)
someconcerns
10/10/2016 9:40:05 AM
28138
If I suffered from chronic UP and nothing had
(1)
thefamilyman
10/10/2016 9:39:09 AM
28137
Absolutely another intended effect. Whether it
someconcerns
10/10/2016 9:38:32 AM
28136
BIG NEWS in my opinion. This was with 50mg doses
Ultimate
10/10/2016 9:35:36 AM
28135
Think it speeds up also the process of people
(1)
NotRichYet2
10/10/2016 9:33:41 AM
28134
Franchise definition: "the right or license
(3)
Ultimate
10/10/2016 9:32:50 AM
28133
I'm sure that publicizing these prelim results
someconcerns
10/10/2016 9:15:42 AM
28132
It's a proof of concept. You always start small,
Drano
10/10/2016 9:12:14 AM
28131
Goes without saying we wish they had a lot more
(1)
NotRichYet2
10/10/2016 9:06:38 AM
28130
Since it should be preserved and may be deleted
(5)
someconcerns
10/10/2016 9:02:58 AM
28129
It's great that " 2 of 4 patients achieved full
(2)
Drano
10/10/2016 8:54:34 AM
28128
Awesome news! Take that shorts!!! Go
(1)
AlanC
10/10/2016 8:33:36 AM
28127
Update: Cellceutix Phase 2 Trial Initial Data
(3)
daydreaming2
10/10/2016 8:05:52 AM
28126
https://www.sciencedaily.com/releases/2016/03/160
(2)
rosalieone
10/10/2016 4:04:02 AM
28125
I would like to think that at least most
someconcerns
10/09/2016 6:35:26 PM
28124
I read about weight loss.
grotty
10/09/2016 6:19:56 PM
28123
In a fast food society like ours . depending on
NotRichYet2
10/09/2016 5:54:33 PM
28122
I recall an article declaring a possible link
Dynabolic
10/09/2016 5:45:20 PM
28121
I read about weight loss.
grotty
10/09/2016 5:41:07 PM
28120
Question on KEVETRIN . I know and have seen
NotRichYet2
10/09/2016 4:50:14 PM
28119
Would think investors in OTHER BIO stocks who are
(1)
NotRichYet2
10/09/2016 4:41:38 PM
28118
I think they pasted some new opening paragraphs
Drano
10/09/2016 3:36:28 PM
28117
Exactly, and it would also be utterly unethical.
Drano
10/09/2016 3:35:51 PM
28116
Nothing new in this article
grotty
10/09/2016 1:25:40 PM
28115
Who would subject themselves to a trial with the
grotty
10/09/2016 1:16:00 PM
28114
Why the BS about needing control groups in cancer
(1)
Drano
10/09/2016 12:18:03 PM
28113
Yes I'm familiar with the patent process as I too
Kelt
10/09/2016 11:08:58 AM
28112
I'm not saying they didn't have costs.I am saying
Kelt
10/09/2016 10:56:38 AM
28111
No, CTIX did have significant costs -- typically
(3)
Drano
10/09/2016 10:29:23 AM
28110
In Re: ; (3) the significant costs incurred by
(3)
Kelt
10/09/2016 10:12:43 AM
28108
I think we'll get an update on the first cohort
(1)
sox0407
10/08/2016 8:36:59 PM
28107
LR read your post and all the replies. I'm 100%
sox0407
10/08/2016 7:06:09 PM
28106
Well, I finally had the chance to sit and read
(8)
someconcerns
10/08/2016 5:50:51 PM
28104
I think we're going to have to start referring to
Drano
10/08/2016 3:58:18 PM
28103
The Muppets are not going to like that
incubus
10/08/2016 3:50:52 PM
Newer
Older
Recent Articles
Innovative Steps Towards AI in Healthcare Quality Measurement
Leadership Change at Diamond Antenna: New CEO and CFO Appointed
Zillow Stock Update: Positive Trends and Investor Insights
Novelis Unveils Progressive Sustainability Report Insights
Freeport-McMoRan Faces Challenges Following Indonesia Incident
The Future of EV and ESS Battery Pouch Film Growth
Investor Alert: LifeMD, Inc. Faces Lawsuit Over Stock Issues
CareSource Foundation Grant Challenge Empowers Local Nonprofits
Unlocking the Future: Agents.Land's Permissionless Platform for Creators
Understanding the Upcoming Earnings of Legacy Education Inc.
Enhancing Industrial Connectivity with Belden's Solutions
Micron Technology's Strong Q4 Performance and Analysts' Reactions
Innovative Dietary Approaches Target Deadly Pediatric Cancer
IONIQ 9 Recognized Among Top Engines in Powerful EV Category
InventHelp's Innovative Paddle Game Promises Fun and Fitness
NEXUS Luxury Collection Expands Global Footprint with Purple Dragon
Investing in Tyler Technologies: A 20-Year Journey of Growth
Revolutionizing Content Creation: Agents.Land Unleashed
Updates for Shareholders of Cytokinetics and Oher Companies
Faruqi & Faruqi Investigates Semler Scientific for Investors
CEO David Fisher's Major Stock Option Exercise at Enova
Synopsys Insider Deal: Sudhindra Kankanwadi's $6M Stock Options
Randall K Fields Sells $122K Worth of ReposiTrak Shares Today
John Swallow's Notable Insider Sale of Idaho Strategic Resources Stock
Mona Chu's Strategic Stock Move: Insights on Pure Storage
Insider Moves: Mark F Bowser's $84K Investment in Daktronics
Kenneth L Calloway's $452K Share Sale: What It Means for CENX
In-Depth Competitor Analysis of NVIDIA and Market Rivals
Guideline Adjusts Revenue Claims Following NAD Recommendations
Comprehensive Evaluation of Microsoft in Software Sector
Otus Achieves Certification for Data Privacy Excellence
Understanding Royal Gold Inc's Earnings Dynamics and Market Value
Meta Platforms Analysis: Insights Into Competitive Positioning
Innovative Paper Towel Stand Redefines Hygiene and Convenience
Xone Chain Enhances Blockchain Ecosystem with Launch and Compliance
FirstEnergy Foundation's Record Grant to Tackle Local Hunger
Comparative Insights on Amazon.com Among Retail Giants
BranchLab Forms Innovative Scientific Advisory Board for AI Progress
Devon Energy to Release Q3 2025 Earnings and Host Call
Exciting New Season of Back of House Celebrates Mohegan Sun
Vishay Intertechnology Unveils Advanced Hyperfast Rectifiers
Exploring Apple's Position Among Key Tech Hardware Rivals
Interlink Electronics Unveils Major Stock Dividend Announcement
ShopBack Appoints Carolina Paradas as U.S. GM to Drive Growth
Zealand Pharma Welcomes Rachel James-Owens As New VP
QuEra's New Fault Tolerance Breakthrough for Quantum Computing
Exploring Recent Bullish Trends in JPMorgan Chase Options Activity
Understanding the Options Landscape for GE Vernova (GEV)
Excel Medical Achieves Recognition Among Fastest-Growing Firms
Market Insights into Amphenol's Options Trading Activity